118 related articles for article (PubMed ID: 28396268)
1. Understanding Alzheimer's disease by global quantification of protein phosphorylation and sialylated N-linked glycosylation profiles: A chance for new biomarkers in neuroproteomics?
Lassen PS; Thygesen C; Larsen MR; Kempf SJ
J Proteomics; 2017 May; 161():11-25. PubMed ID: 28396268
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive protocol to simultaneously study protein phosphorylation, acetylation, and N-linked sialylated glycosylation.
Melo-Braga MN; Ibáñez-Vea M; Larsen MR; Kulej K
Methods Mol Biol; 2015; 1295():275-92. PubMed ID: 25820729
[TBL] [Abstract][Full Text] [Related]
3. Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry.
Skorobogatko YV; Deuso J; Adolf-Bryfogle J; Nowak MG; Gong Y; Lippa CF; Vosseller K
Amino Acids; 2011 Mar; 40(3):765-79. PubMed ID: 20563614
[TBL] [Abstract][Full Text] [Related]
4. Post-translational modifications of tau protein in Alzheimer's disease.
Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
[TBL] [Abstract][Full Text] [Related]
5. Interplay between protein glycosylation pathways in Alzheimer's disease.
Frenkel-Pinter M; Shmueli MD; Raz C; Yanku M; Zilberzwige S; Gazit E; Segal D
Sci Adv; 2017 Sep; 3(9):e1601576. PubMed ID: 28929132
[TBL] [Abstract][Full Text] [Related]
6. Post-translational modifications of tau protein: implications for Alzheimer's disease.
Martin L; Latypova X; Terro F
Neurochem Int; 2011 Mar; 58(4):458-71. PubMed ID: 21215781
[TBL] [Abstract][Full Text] [Related]
7. Identification, Quantification, and Site Localization of Protein Posttranslational Modifications via Mass Spectrometry-Based Proteomics.
Ke M; Shen H; Wang L; Luo S; Lin L; Yang J; Tian R
Adv Exp Med Biol; 2016; 919():345-382. PubMed ID: 27975226
[TBL] [Abstract][Full Text] [Related]
8. Improving the Phosphoproteome Coverage for Limited Sample Amounts Using TiO2-SIMAC-HILIC (TiSH) Phosphopeptide Enrichment and Fractionation.
Engholm-Keller K; Larsen MR
Methods Mol Biol; 2016; 1355():161-77. PubMed ID: 26584925
[TBL] [Abstract][Full Text] [Related]
9. Evolving Relevance of Neuroproteomics in Alzheimer's Disease.
Lista S; Zetterberg H; O'Bryant SE; Blennow K; Hampel H
Methods Mol Biol; 2017; 1598():101-115. PubMed ID: 28508359
[TBL] [Abstract][Full Text] [Related]
10. Post-translational modifications of tau protein.
Pevalova M; Filipcik P; Novak M; Avila J; Iqbal K
Bratisl Lek Listy; 2006; 107(9-10):346-53. PubMed ID: 17262986
[TBL] [Abstract][Full Text] [Related]
11. Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.
Thomas SN; Yang AJ
Methods Mol Biol; 2017; 1523():161-177. PubMed ID: 27975250
[TBL] [Abstract][Full Text] [Related]
12. Modification-specific proteomics in plant biology.
Ytterberg AJ; Jensen ON
J Proteomics; 2010 Oct; 73(11):2249-66. PubMed ID: 20541636
[TBL] [Abstract][Full Text] [Related]
13. Post-translational modifications in Alzheimer's disease and the potential for new biomarkers.
Russell CL; Koncarevic S; Ward MA
J Alzheimers Dis; 2014; 41(2):345-64. PubMed ID: 24662105
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Synaptosomal Proteomics in Alzheimer's Disease.
Ahmad F; Haque S; Chavda V; Ashraf GM
Curr Protein Pept Sci; 2021; 22(6):479-492. PubMed ID: 34148536
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.
Kanninen K; Goldsteins G; Auriola S; Alafuzoff I; Koistinaho J
Neurosci Lett; 2004 Sep; 367(2):235-40. PubMed ID: 15331161
[TBL] [Abstract][Full Text] [Related]
16. Functionalized magnetic nanoparticles for sample preparation in proteomics and peptidomics analysis.
Li Y; Zhang X; Deng C
Chem Soc Rev; 2013 Nov; 42(21):8517-39. PubMed ID: 23933677
[TBL] [Abstract][Full Text] [Related]
17. Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration.
Butterfield DA; Boyd-Kimball D; Castegna A
J Neurochem; 2003 Sep; 86(6):1313-27. PubMed ID: 12950441
[TBL] [Abstract][Full Text] [Related]
18. Neuroproteomics of the Synapse: Subcellular Quantification of Protein Networks and Signaling Dynamics.
van Gelder CAGH; Altelaar M
Mol Cell Proteomics; 2021; 20():100087. PubMed ID: 33933679
[TBL] [Abstract][Full Text] [Related]
19. Explorative and targeted neuroproteomics in Alzheimer's disease.
Brinkmalm A; Portelius E; Öhrfelt A; Brinkmalm G; Andreasson U; Gobom J; Blennow K; Zetterberg H
Biochim Biophys Acta; 2015 Jul; 1854(7):769-78. PubMed ID: 25619854
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.
Beckelman BC; Day S; Zhou X; Donohue M; Gouras GK; Klann E; Keene CD; Ma T
J Alzheimers Dis; 2016 Sep; 54(2):669-78. PubMed ID: 27567813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
